Free Trial

AstraZeneca Guidance, Size for 7Pt Jumbo TBA

PIPELINE
  • Date $MM Issuer (Priced *, Launch #)
  • 05/25 $Benchmark AstraZeneca 7pt jumbo: 2Y +40a, 3NC1 +55a, 3NC1 FRN SOFR, 5Y +65a, 7Y +80a, 10Y +100a, 30Y +115a. For comparison: AZN issued $3B last year Aug 3: $1.2B +5Y +55, $1.3B 10Y +85, $500M 30Y +100.
  • 05/25 $Benchmark Westpac 5Y +62a, 5Y FRN SOFR, 10Y +87a
  • 05/25 $Benchmark Deutsche Bank 3Y +80a, 11NC10 +180a
  • 05/25 $Benchmark Hormel 3NC1 +55a, 7Y +75a, 30Y +105a
  • 05/25 $Benchmark AAC Tech 5Y +185a, 10Y +225s
  • 05/25 $Benchmark Emirate of Abu Dhabi 7Y +70a

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.